Skip to main content

Table 3 Association between MC and genital HPV detection in men by lifetime number of female partners

From: Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study

   Circumcision
  N No Yes
    Univariate Multivariable1
    PR (95% CI) PR (95% CI)
Any HPV
 Lifetime number of female partners     P = 0.1462
  1-4 1099 1.00 0.97 (0.87-1.08) 0.92 (0.81-1.03)
  5-12 1183 1.00 0.98 (0.91-1.07) 0.96 (0.88-1.05)
  13+ 1083 1.00 1.03 (0.97-1.10) 1.03 (0.96-1.10)
Oncogenic HPV
 Lifetime number of female partners     P = 0.2042
  1-4 667 1.00 0.93 (0.73 - 1.19) 0.96 (0.73 - 1.26)
  5-12 726 1.00 0.96 (0.82 - 1.12) 0.92 (0.77 - 1.09)
  13+ 697 1.00 1.06 (0.95 - 1.18) 1.06 (0.95 - 1.19)
Non-Oncogenic HPV
 Lifetime number of female partners     P = 0.006 2
  1-4 647 1.00 0.62 (0.45 - 0.83) 0.59 (0.42 - 0.83)
  5-12 668 1.00 0.89 (0.74 - 1.07) 0.88 (0.72 - 1.08)
  13+ 542 1.00 1.03 (0.88 - 1.20) 1.03 (0.88 - 1.21)
Unclassified HPV
 Lifetime number of female partners     P = 0.9522
  1-4 717 1.00 1.24 (1.01 – 1.51) 1.03 (0.82 – 1.28)3
  5-12 527 1.00 1.25 (0.96 – 1.61) 1.15 (0.86 – 1.53)3
  13+ 330 1.00 1.19 (0.83 – 1.71) 1.10 (0.74 – 1.62)3
  1. NOTE. PR, prevalence ratio; CI, confidence interval. Numbers in bold correspond to statistically significant point estimates.
  2. 1Adjusted for race, marital status, female sexual partners in past 3–6 months and male anal sexual partners in the past 3 months.
  3. 2Test for interaction between MC and lifetime number of female partners.
  4. 3Adjusted for race, marital status, and male anal sexual partners in the past 3 months.